Keratoconjunctivitis Sicca
📧 Sign up to get email alerts when something new happens for Keratoconjunctivitis Sicca.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease [Phase 3]
Phase 3 safety and efficacy study of Tavilermide (MIM-D3) ophthalmic solution for dry eye disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye [Phase 3]
Phase 3 trial assessing safety and efficacy of Tavilermide (MIM-D3) ophthalmic solution for dry eye (keratoconjunctivitis sicca) has complet…
-
CLINICAL_TRIALS withdrawal · 2019-05-17Clinical Trial Update: Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease [Phase 4]
A Phase 4 clinical trial investigating the effects of Xiidra on closed-eye tear film leukocytes in dry eye disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome [NA]
Clinical trial evaluated safety and effectiveness of an intranasal lacrimal neurostimulator for dry eye syndrome; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca [Phase 3]
Phase 3 study of OTX-101 for keratoconjunctivitis sicca completed with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca [Phase 3]
Open-label extension of a phase 3 study evaluating OTX-101 for keratoconjunctivitis sicca has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca [Phase 2, Phase 3]
A phase 2/3 dose-ranging trial evaluated the safety and efficacy of OTX-101 for keratoconjunctivitis sicca (dry eye disease); the study has …
-
CLINICAL_TRIALS withdrawal · 2018-12-14Clinical Trial Update: Repository Corticotropin Injection in Keratoconjunctivitis Sicca [Phase 4]
A Phase 4 trial of repository corticotropin injection for keratoconjunctivitis sicca has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye [Phase 3]
Phase 3 clinical trial evaluating two concentrations of autologous serum for treatment of severe dry eye; current status unknown.
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator [NA]
Six-month study assessing the safety and effectiveness of the intranasal lacrimal neurostimulator; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator [NA]
Completed clinical trial evaluating acute tear production after a single use of the Oculeve intranasal neurostimulator; results were posted …
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Laser Therapy to Treat the Dry Mouth of Sjogren's Syndrome [NA]
A completed clinical trial evaluated laser therapy for dry mouth associated with Sjögren's syndrome. Results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome [Phase 2]
Phase 2 clinical trial update assessing the effects of B-cell depletion in patients with Primary Sjögren's Syndrome; the study status is COM…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1) [Phase 3]
Phase 3 clinical trial of SAR 1118 for dry eye disease and keratoconjunctivitis sicca completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of R932348 ophthalmic solution in patients with Keratoconjunctivitis Sicca; result…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
A completed TearLab core validation trial aimed at establishing referent values for Dry Eye Disease, specifically Keratoconjunctivitis Sicca…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye [Phase 4]
Phase 4 trial update for OPTIVE FUSION with VISMED Multi in dry eye conditions shows completed study with posted results.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye [Phase 3]
Phase 3 clinical trial update for INS365 Ophthalmic Solution in keratoconjunctivitis sicca (dry eye) has completed.
-
CLINICAL_TRIALS research · 2015-04-23Clinical Trial Update: Three Dimension Tomography of Eye Structures by White Light Imaging Device
Clinical trial update about a three-dimensional tomography imaging device for eye structures using white-light imaging, studied in healthy s…
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Trial of CF101 to Treat Patients With Dry Eye Disease [Phase 3]
Phase 3 trial of CF101 for dry eye disease (keratoconjunctivitis sicca) completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease [Phase 1]
Phase 1 safety, tolerability and pharmacokinetics study of R932348 eye drops in keratoconjunctivitis Sicca (dry eye disease) has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome [Phase 4]
This update indicates that the Phase 4 study evaluating Retaine for signs and symptoms of Keratoconjunctivitis Sicca (dry eye) has been comp…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Tear Film Break-up Time After Instillation of Artificial Tears [NA]
A clinical trial evaluated tear film break-up time after instillation of artificial tears in keratoconjunctivitis sicca and has completed wi…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Dry Eye Assessment and Management: Feasibility Study [Phase 2, Phase 3]
A Phase 2/3 feasibility study of Dry Eye Assessment and Management completed with results posted in 2012, evaluating dry eye disease and ker…
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS) [Phase 1]
Phase 1 dose-escalation study to evaluate safety and tolerability of LX214 ophthalmic solution in healthy volunteers, followed by open-label…